Yup valuation is the only issue, the company is doing very well. If it goes lower around the $40 mark, that's cheap and a significant buffer for margin of error.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
